Details for New Drug Application (NDA): 022244

✉ Email this page to a colleague

« Back to Dashboard

NDA 022244 describes LUSEDRA, which is a drug marketed by Eisai Inc and is included in one NDA. There is one patent protecting this drug. Additional details are available on the LUSEDRA profile page.

The generic ingredient in LUSEDRA is fospropofol disodium. Additional details are available on the fospropofol disodium profile page.

Summary for 022244

Tradename:	LUSEDRA
Applicant:	Eisai Inc
Ingredient:	fospropofol disodium
Patents:	1

DrugPatentWatch^® Estimated Generic Entry Opportunity Date for 022244

Generic Entry Date for 022244^: See Plans and Pricing* Constraining patent/regulatory exclusivity: See Plans and Pricing Dosage: SOLUTION;INTRAVENOUS

^*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	SOLUTION;INTRAVENOUS			Strength	1050MG/30ML (35MG/ML)
Approval Date:	Dec 12, 2008	TE:		RLD:	No
Patent:	See Plans and Pricing	Patent Expiration:	Jul 1, 2022	Product Flag?	Y	Substance Flag?	Y	Delist Request?
Patented Use:	SEDATIVE-HYPNOTIC AGENT INDICATED FOR MONITORED ANESTHESIA CARE (MAC) SEDATION

Expired US Patents for NDA 022244

Subscribe to access the full database, or Try it Free
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Eisai Inc	LUSEDRA	fospropofol disodium	SOLUTION;INTRAVENOUS	022244-001	Dec 12, 2008	See Plans and Pricing	See Plans and Pricing
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Summary for 022244

DrugPatentWatch® Estimated Generic Entry Opportunity Date for 022244

Profile for product number 001

Make Better Decisions: Try a trial or see plans & pricing

DrugPatentWatch^® Estimated Generic Entry Opportunity Date for 022244